Cargando…
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants
AIMS: To evaluate the timing and spectral-domain optical coherence tomography (SD-OCT) features of diabetic macular oedema (DME) recurrence according to baseline OCT patterns in patients treated with dexamethasone implant (DEX-I). METHODS: This is a retrospective observational study (72 eyes/65 pati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311372/ https://www.ncbi.nlm.nih.gov/pubmed/32114643 http://dx.doi.org/10.1007/s00592-020-01504-w |
_version_ | 1783549521881464832 |
---|---|
author | Eandi, Chiara M. De Geronimo, Daniele Giannini, Daniela Polito, Maria Sole Tosi, Gian Marco Neri, Giovanni Le Mer, Yannick Varano, Monica Parravano, Mariacristina |
author_facet | Eandi, Chiara M. De Geronimo, Daniele Giannini, Daniela Polito, Maria Sole Tosi, Gian Marco Neri, Giovanni Le Mer, Yannick Varano, Monica Parravano, Mariacristina |
author_sort | Eandi, Chiara M. |
collection | PubMed |
description | AIMS: To evaluate the timing and spectral-domain optical coherence tomography (SD-OCT) features of diabetic macular oedema (DME) recurrence according to baseline OCT patterns in patients treated with dexamethasone implant (DEX-I). METHODS: This is a retrospective observational study (72 eyes/65 patients). Best-corrected visual acuity, timing of DME recurrence, and SD-OCT pattern [intraretinal cysts (IRC), IRC plus subretinal fluid (mixed), external limiting membrane (ELM), ellipsoid (IS/OS) layer integrity] were assessed at baseline and monthly until first DME recurrence. RESULTS: Forty-two (58.3%) and 30 (41.6%) DME eyes had an IRC and mixed DME pattern at baseline, respectively. Twenty-four out of thirty mixed eyes (80%) relapsed without subretinal fluid. At baseline, mixed eyes showed similar changes in ELM and IS/OS (60 and 76.6% of eyes, respectively) versus IRC eyes (42.8 and 80.9% of eyes). After DME recurrence, more mixed eyes at baseline showed ELM and IS/OS changes (63.3 and 86.6%) than IRC eyes (50 and 76.2%). 33.3% of mixed eyes had DME recurrence at ≥ 6 months from first DEX-I implant versus 19% of IRC eyes. CONCLUSIONS: Mixed DME eyes were treated with DEX-I relapse later and more frequently without subretinal fluid than IRC eyes. SD-OCT characteristics of different DME patterns at baseline can predict morphological features and timing of DME recurrence. |
format | Online Article Text |
id | pubmed-7311372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-73113722020-06-26 Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants Eandi, Chiara M. De Geronimo, Daniele Giannini, Daniela Polito, Maria Sole Tosi, Gian Marco Neri, Giovanni Le Mer, Yannick Varano, Monica Parravano, Mariacristina Acta Diabetol Original Article AIMS: To evaluate the timing and spectral-domain optical coherence tomography (SD-OCT) features of diabetic macular oedema (DME) recurrence according to baseline OCT patterns in patients treated with dexamethasone implant (DEX-I). METHODS: This is a retrospective observational study (72 eyes/65 patients). Best-corrected visual acuity, timing of DME recurrence, and SD-OCT pattern [intraretinal cysts (IRC), IRC plus subretinal fluid (mixed), external limiting membrane (ELM), ellipsoid (IS/OS) layer integrity] were assessed at baseline and monthly until first DME recurrence. RESULTS: Forty-two (58.3%) and 30 (41.6%) DME eyes had an IRC and mixed DME pattern at baseline, respectively. Twenty-four out of thirty mixed eyes (80%) relapsed without subretinal fluid. At baseline, mixed eyes showed similar changes in ELM and IS/OS (60 and 76.6% of eyes, respectively) versus IRC eyes (42.8 and 80.9% of eyes). After DME recurrence, more mixed eyes at baseline showed ELM and IS/OS changes (63.3 and 86.6%) than IRC eyes (50 and 76.2%). 33.3% of mixed eyes had DME recurrence at ≥ 6 months from first DEX-I implant versus 19% of IRC eyes. CONCLUSIONS: Mixed DME eyes were treated with DEX-I relapse later and more frequently without subretinal fluid than IRC eyes. SD-OCT characteristics of different DME patterns at baseline can predict morphological features and timing of DME recurrence. Springer Milan 2020-02-29 2020 /pmc/articles/PMC7311372/ /pubmed/32114643 http://dx.doi.org/10.1007/s00592-020-01504-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Eandi, Chiara M. De Geronimo, Daniele Giannini, Daniela Polito, Maria Sole Tosi, Gian Marco Neri, Giovanni Le Mer, Yannick Varano, Monica Parravano, Mariacristina Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants |
title | Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants |
title_full | Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants |
title_fullStr | Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants |
title_full_unstemmed | Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants |
title_short | Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants |
title_sort | baseline sd-oct characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311372/ https://www.ncbi.nlm.nih.gov/pubmed/32114643 http://dx.doi.org/10.1007/s00592-020-01504-w |
work_keys_str_mv | AT eandichiaram baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT degeronimodaniele baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT gianninidaniela baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT politomariasole baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT tosigianmarco baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT nerigiovanni baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT lemeryannick baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT varanomonica baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants AT parravanomariacristina baselinesdoctcharacteristicsofdiabeticmacularoedemapatternscanpredictmorphologicalfeaturesandtimingofrecurrenceinpatientstreatedwithdexamethasoneintravitrealimplants |